TARGET AUDIENCE
The target audience for this
educational activity is pediatric endocrinologists, pediatricians,
neonatologists, and other pediatric specialists.
PROGRAM
DESCRIPTION
Improving Care for Patients with Turner
Syndrome will focus on the areas in which improvements in
patient management are most urgently needed: expediting the diagnosis of
Turner syndrome, ensuring that newly diagnosed patients receive
necessary screenings and that established patients receive necessary
monitoring at recommended intervals, and making sure that patients
receive hormone replacement therapy (growth hormone and estrogen) using
the right agent, beginning at the right time, at the most appropriate,
individualized doses, and for the optimal duration.
Our faculty will review the new international Turner syndrome clinical
practice guidelines. The presenters will summarize key recommendations
contained in the 2017 guidelines and highlight the ways in which
recommendations have changed since 2007.
There is no fee to participate in this symposium.
LEARNING
OBJECTIVES
After attending this symposium, the participant should be better
able to:
• Adopt best practices for
expediting the diagnosis of Turner syndrome •
Incorporate into practice current international guidance for
screening newly diagnosed
patients for Turner syndrome-related conditions and for
monitoring established patients at
recommended intervals • Optimize patient
outcomes by ensuring that individuals with Turner syndrome receive
the
most appropriate regimens of growth hormone therapy and
estrogen replacement therapy
|
JOINTLY
PROVIDED BY:

This activity has been planned and
implemented in accordance with the accreditation requirements and
policies of the Accreditation Council for Continuing Medical Education
(ACCME) through the joint providership of American Academy of CME, Inc.
and Scherer Clinical Communications. American Academy of CME, Inc. is
accredited by the ACCME to provide continuing medical education for
physicians.
American Academy of CME, Inc. designates this live activity for a
maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should
claim only the credit commensurate with the extent of their
participation in the activity.
DISCLOSURE
According to the disclosure policy of the
Academy, faculty, editors, managers, and other individuals who are in a
position to control content are required to disclose any significant
relationships with relevant commercial companies related to this
activity. All relevant conflicts of interest that are identified are
reviewed. If a conflict is identified, it is the responsibility of the
Academy to initiate a mechanism to resolve the conflict(s). The
existence of these interests or relationships is not viewed as implying
bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific
objectivity of studies reported, and levels of evidence.
The opinions expressed in this educational activity are those of the
faculty, and do not represent those of Academy or Scherer Clinical
Communications. This activity is intended as a supplement to existing
knowledge, published information, and practice guidelines. Learners
should appraise the information presented critically and draw
conclusions only after careful consideration of all available scientific
information.
PRELIMINARY AGENDA
Welcome
Philippe F. Backeljauw, MD- Chair
Early Identification of Turner Syndrome- Diagnostic and Genetic
Aspects
Philippe F. Backeljauw, MD
Growth Hormone, Estrogen, and Fertility Issues in Turner Syndrome
Nelly Mauras, MD
Evaluation and Monitoring of Comorbidities Found with Turner Syndrome
Claus Gravholt, MD
Panel Discussion and Closing Remarks
FACULTY
Philippe F. Backeljauw, MD
Director, Cincinnati Center for Pediatric and
Adult Turner Syndrome Care
Fellowship Program Director, Division of Endocrinology
Professor of Clinical Pediatrics
Cincinnati Children’s Hospital Medical Center
University of Cincinnati College of Medicine
Cincinnati, OH
Nelly Mauras, MD
Chief, Division of Endocrinology, Diabetes & Metabolism
Nemours Children’s Health System
Professor of Pediatrics
Mayo College of Medicine
Jacksonville, FL
Claus Hojbjerg Gravholt, MD, PhD, DMSc
Professor
Department of Endocrinology and Internal Medicine (MEA) and
Department of Molecular Medicine (MOMA)
Aarhus University Hospital
Aarhus, Denmark
|